Skip to content

Clinical trials

Phase 2/3 trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Lithuania Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20074
20082
20092
20102
20111
20133
20162
20173
20182
20192
20201
20222
20232
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting7
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
AbbVie2
Artu Biologicals2
Boehringer Ingelheim2
Kartos Therapeutics, Inc.2
Novartis Pharmaceuticals2
Pfizer2
argenx2
ASLAN Pharmaceuticals1
Astellas Pharma Europe B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative4
Arthritis, Rheumatoid3
Crohn Disease2
Hidradenitis Suppurativa2
Hypersensitivity2
Stomach Neoplasms2
Amyloidosis1
Asthma1
Dermatomyositis1
Diabetes Mellitus, Type 21

Trials

Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.